E

electroCore
D

ECOR

5.86000
USD
-0.77
(-11.61%)
مغلق
حجم التداول
1,414
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
42,151,519
أصول ذات صلة
A
AMRC
-0.990
(-8.11%)
11.210 USD
A
ARTL
-0.08000
(-8.08%)
0.91000 USD
B
BGFV
-0.04150
(-4.27%)
0.93000 USD
C
CLSK
-0.60500
(-7.55%)
7.40500 USD
المزيد
الأخبار المقالات

العنوان: electroCore

القطاع: Healthcare
الصناعة: Medical Devices
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated withmigraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.